Skip to main content

Table 1 Patients’ clinicopathological characteristics and treatment details

From: Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique

Characteristics

Primary cytoreduction

Secondary cytoreduction

All cases, n

6

7

Age, years median (range)

55.4 (40–79)

58.8 (49–73)

FIGO stage

  

 III C

4

5

 IV

2

2

Tumor histotype

  

 Serous

6

7

 Endometriod

0

0

Tumor grade

  

 G1

0

0

 G2–3

6

7

No residual tumor at primary debulking surgery

6

5

PFI-1, months, median (range)

25 (4–36)

23 (12–34)

Estimated blood loss, mL, median (range)

200 (80–550)

50 (30–200)

Operative time, min, median (range)

509 (200–845)

253 (90–380)

Hospital stay, days, median (range)

9 (5–18)

3 (2–5)

PFI-2, months, median (range)

NA

Median not reached

  1. FIGO International Federation of Gynecology and Obstetrics, PFI-1 primary platinum-free interval after primary cytoreductive surgery, PFI-2 primary platinum-free interval after secondary cytoreductive surgery